Streetbeat News

Earnings

NPCE

Neuroplace reported better-than-expected Q2 financial results, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 2:11 pm

KVHI

KVH Industries reported worse-than-expected Q2 financial results, leading to a drop in its share price.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 2:10 pm

SALM

Salem Media Group reported worse-than-expected Q2 earnings per share (EPS) results, leading to a drop in its share price.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 2:10 pm

RYAM

Rayonier Advanced Materials (RYAM) reported worse-than-expected Q2 financial results, leading to a decrease in its share price.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 2:09 pm

CRL

DBTX

NVEI

PALI

RENB

TNGX

TYGO

US stocks were mostly lower with the Nasdaq Composite falling more than 50 points. Charles River Laboratories International, Inc. (CRL) reported better-than-expected Q2 results and raised its FY23 non-GAAP EPS estimate. Tango Therapeutics (TNGX), Decibel Therapeutics (DBTX), and Renovaro Biosciences (RENB) saw their shares rise significantly. Palisade Bio (PALI), Tigo Energy (TYGO), and Nuvei Corporation (NVEI) shares fell due to disappointing results and guidance.

Portfolio Pulse from Lisa Levin

August 09, 2023 | 2:09 pm

VST

Vista Corp reported its Q2 financial results and updated its FY23 guidance, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 2:08 pm

BIRD

Allbirds reported better-than-expected Q2 financial results, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 2:08 pm

VRM

Vroom reported worse-than-expected Q2 sales results, leading to a decrease in its share price.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 2:06 pm

VERI

Veritone reported worse-than-expected Q2 financial results, leading to a decrease in its share price.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 2:05 pm

FLT

FleetCor Technologies reported better-than-expected Q2 financial results and issued FY23 revenue guidance above estimates. Morgan Stanley raised its price target from $243 to $244 on the stock.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 2:05 pm